KSS
26
-15
EFX
41
-5
NVDA
54
2
HPQ
66
6
SHW
68
-5
NWSA
63
-4
CMCSA
48
-2
LB
60
4
FDX
44
-2
ETR
72
3
WY
60
-2
LEN
57
-4
EW
46
3
LH
45
-3
OKE
78
3
KO
47
-2
HOG
36
-3
VFC
50
-2
LYB
41
-2
CVS
52
-6
KSS
26
-15
EFX
41
-5
NVDA
54
2
HPQ
66
6
SHW
68
-5
NWSA
63
-4
CMCSA
48
-2
LB
60
4
FDX
44
-2
ETR
72
3
WY
60
-2
LEN
57
-4
EW
46
3
LH
45
-3
OKE
78
3
KO
47
-2
HOG
36
-3
VFC
50
-2
LYB
41
-2
CVS
52
-6
Financhill
Back

Halozyme Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
53

HALO
Halozyme Therapeutics

Last Price:
47.79
Seasonality Move:
17.34%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
130.47
Seasonality Move:
14.88%
Buy
53
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $47.79. The Score for HALO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $47.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.26 Sell
Relative Strength Index (14 RSI): 41.07 Sell
Chaikin Money Flow: 837944 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.59 - 58.19) Sell
Bollinger Bands (100): (51.1 - 60.64) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.13 Buy
20-day SMA: 52.96 Sell
50-day SMA: 54.19 Sell
200-day SMA: 49.33 Sell
8-day EMA: 48.36 Sell
20-day EMA: 50.94 Sell
50-day EMA: 53.37 Sell
200-day EMA: 50.43 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):